Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 31 articles:
HTML format
Text format



Single Articles


    March 2010
  1. QUINT KD , de Koning MN, van Doorn LJ, Quint WG, et al
    HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. CHAO FY , Chao A, Huang CC, Hsueh S, et al
    Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  3. LINDELL G , Nasman A, Jonsson C, Ehrsson RJ, et al
    Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. GIULIANO AR , Anic G, Nyitray AG
    Epidemiology and pathology of HPV disease in males.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


  5. KANE MA
    Global implementation of human papillomavirus (HPV) vaccine: Lessons from hepatitis B vaccine.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. ZIMET GD , Rosenthal SL
    HPV vaccine and males: Issues and challenges.
    Gynecol Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  7. GNANAMONY M , Peedicayil A, Subhashini J, Ram TS, et al
    Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


  8. MCKENZIE ND , Kobetz EN, Hnatyszyn J, Twiggs LB, et al
    Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  9. CASTELLSAGUE X , Schneider A, Kaufmann AM, Bosch FX, et al
    HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  10. BANSAL M , Austin RM, Zhao C
    High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  11. CROCHARD A , Luyts D, di Nicola S, Goncalves MA, et al
    Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: Implications for HPV vaccination programs.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


  12. JIMENEZ W , Paszat L, Kupets R, Wilton A, et al
    Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


  13. QUINT KD , de Koning MN, Geraets DT, Quint WG, et al
    Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  14. ZHOU X , Han S, Wang S, Chen X, et al
    Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  15. DAVID MP , Van Herck K, Hardt K, Tibaldi F, et al
    Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  16. WATTS LA , Joseph N, Wallace M, Rauh-Hain JA, et al
    HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
    Gynecol Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  17. VIJAYARAGHAVAN A , Efrusy M, Lindeque G, Dreyer G, et al
    Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  18. MENNINI FS , Giorgi Rossi P, Palazzo F, Largeron N, et al
    Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


  19. DE MARCHI TRIGLIA R , Metze K, Zeferino LC, Lucci De Angelo Andrade LA, et al
    HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  20. CASTELLSAGUE X
    Natural history and epidemiology of HPV infection and cervical cancer.
    Gynecol Oncol. 2008;110.
    PubMed     Text format     Related articles    Abstract available


    July 2008
  21. SCHWARZ TF , Leo O
    Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


  22. JENKINS D
    A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


  23. HARPER DM
    Impact of vaccination with Cervarixtrade mark on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.
    Gynecol Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  24. WRIGHT TC JR , Huh WK, Monk BJ, Smith JS, et al
    Age considerations when vaccinating against HPV.
    Gynecol Oncol. 2008;109.
    PubMed     Text format     Related articles    Abstract available


  25. HERZOG TJ , Huh WK, Downs LS, Smith JS, et al
    Initial lessons learned in HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Text format     Related articles    Abstract available


  26. MYERS E , Huh WK, Wright JD, Smith JS, et al
    The current and future role of screening in the era of HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Text format     Related articles    Abstract available


  27. MONK BJ , Herzog TJ
    The new era of cervical cancer prevention: HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Text format     Related articles   


  28. STANLEY M
    Immunobiology of HPV and HPV vaccines.
    Gynecol Oncol. 2008;109.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  29. SIRIAUNKGUL S , Suwiwat S, Settakorn J, Khunamornpong S, et al
    HPV genotyping in cervical cancer in Northern Thailand Adapting the linear array HPV assay for use on paraffin-embedded tissue.
    Gynecol Oncol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  30. PARK JY , Lee KH, Dong SM, Kang S, et al
    The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
    Gynecol Oncol. 2008;.
    PubMed     Text format     Related articles    Abstract available


    November 2007
  31. AULT KA
    Human papillomavirus vaccines and the potential for cross-protection between related HPV types.
    Gynecol Oncol. 2007;107.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: